Max Robotics — Global Service Robot Directory + US Certification

About

Jing Sheng is a leading figure in urologic oncology, with a focused expertise in minimally invasive kidney surgery. Her research centers on the comparative effectiveness and technical refinement of robotic partial nephrectomy (RPN) versus traditional open surgery. Sheng’s major contribution is providing high-level, evidence-based data demonstrating that RPN offers comparable oncologic outcomes with significantly reduced perioperative morbidity. Her landmark 2014 systematic review and meta-analysis, cited over 148 times, critically synthesized the early evidence, establishing RPN as a safe and effective alternative to open partial nephrectomy. She further validated these findings through a rigorous propensity-score matched study (29 citations), which controlled for patient selection bias to confirm superior perioperative recovery and preserved early renal function with the robotic approach. Sheng also advanced surgical planning by investigating how tumor anatomy—quantified by scoring systems like RENAL and centrality index—correlates with warm ischemia time, a critical factor for renal function preservation. Her work has been instrumental in shifting the paradigm toward robotic nephron-sparing surgery, providing the foundational evidence that guides current clinical practice and patient counseling.